Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L I Kozlovskaya

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Terapevticheskii Arkhiv|December 28, 2024
[Problems of poliomyelitis eradication]O E Ivanova, Y M Mikhailova, L I Kozlovskaya, et al.
Public Health|August 1, 2020
Cases of aseptic meningitis after vaccination against mumps in Russia (2009-2019)I K Belyaletdinova, I V Mitrofanova, L I Kozlovskaya, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 5, 2018
[A case of vaccine-associated paralytic poliomyelitis in an infant]A S Shishov, O E Ivanova, A K Shakaryan, et al.
Springerplus|December 19, 2015
Genetic description of a tick-borne encephalitis virus strain Sofjin with the longest history as a vaccine strainM F Vorovitch, L I Kozlovskaya, L Iu Romanova, et al.
Molekuliarnaia Biologiia|May 27, 2022
[New Analogues of Uridine as Possible Anti-Viral Agents Specific to SARS-CoV-2]A A Maslova, E C Matyugina, E Yu Shustova, et al.
Molecular Biology|June 13, 2022
New Analogues of Uridine as Possible Anti-Viral Agents Specific to SARS-CoV-2A A Maslova, E C Matyugina, E Yu Shustova, et al.
Acta Naturae|February 7, 2022
Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5'-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2E S Matyugina, M S Novikov, L I Kozlovskaya, et al.
Vaccine|March 26, 2016
Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain SofjinL L Chernokhaeva, Yu V Rogova, M F Vorovitch, et al.
Biomeditsinskaia Khimiia|June 18, 2021
[Peptide inhibitors of the interaction of the SARS-CoV-2 receptor-binding domain with the ACE2 cell receptor]R Sh Bibilashvili, M V Sidorova, U S Dudkina, et al.
Biochemistry (Moscow) Supplement. Series B, Biomedical Chemistry|November 8, 2021
Peptide Inhibitors of the Interaction of the SARS-CoV-2 Receptor-Binding Domain with the ACE2 Cell ReceptorR Sh Bibilashvili, M V Sidorova, U S Dudkina, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Terapevticheskii Arkhiv|December 28, 2024
[Problems of poliomyelitis eradication]O E Ivanova, Y M Mikhailova, L I Kozlovskaya, et al.
Public Health|August 1, 2020
Cases of aseptic meningitis after vaccination against mumps in Russia (2009-2019)I K Belyaletdinova, I V Mitrofanova, L I Kozlovskaya, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 5, 2018
[A case of vaccine-associated paralytic poliomyelitis in an infant]A S Shishov, O E Ivanova, A K Shakaryan, et al.
Springerplus|December 19, 2015
Genetic description of a tick-borne encephalitis virus strain Sofjin with the longest history as a vaccine strainM F Vorovitch, L I Kozlovskaya, L Iu Romanova, et al.
Molekuliarnaia Biologiia|May 27, 2022
[New Analogues of Uridine as Possible Anti-Viral Agents Specific to SARS-CoV-2]A A Maslova, E C Matyugina, E Yu Shustova, et al.
Molecular Biology|June 13, 2022
New Analogues of Uridine as Possible Anti-Viral Agents Specific to SARS-CoV-2A A Maslova, E C Matyugina, E Yu Shustova, et al.
Acta Naturae|February 7, 2022
Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5'-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2E S Matyugina, M S Novikov, L I Kozlovskaya, et al.
Vaccine|March 26, 2016
Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain SofjinL L Chernokhaeva, Yu V Rogova, M F Vorovitch, et al.
Biomeditsinskaia Khimiia|June 18, 2021
[Peptide inhibitors of the interaction of the SARS-CoV-2 receptor-binding domain with the ACE2 cell receptor]R Sh Bibilashvili, M V Sidorova, U S Dudkina, et al.
Biochemistry (Moscow) Supplement. Series B, Biomedical Chemistry|November 8, 2021
Peptide Inhibitors of the Interaction of the SARS-CoV-2 Receptor-Binding Domain with the ACE2 Cell ReceptorR Sh Bibilashvili, M V Sidorova, U S Dudkina, et al.
Pageof 2